What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His main research concerns Internal medicine, Endocrinology, Cell biology, Pathology and Immunology.
While the research belongs to areas of Internal medicine, Masataka Sata spends his time largely on the problem of Cardiology, intersecting his research to questions surrounding Diastole.
As a member of one scientific family, he mostly works in the field of Endocrinology, focusing on Signal transduction and, on occasion, Protein kinase A and Downregulation and upregulation.
He has included themes like Endothelial stem cell, Fas ligand, Cellular differentiation, Apoptosis and Neointima in his Cell biology study.
His Endothelial stem cell study integrates concerns from other disciplines, such as Extracellular matrix and Homing.
His work carried out in the field of Pathology brings together such families of science as Progenitor cell and Myocyte.
His most cited work include:
- Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis (1072 citations)
- Role of Adiponectin in Preventing Vascular Stenosis THE MISSING LINK OF ADIPO-VASCULAR AXIS (740 citations)
- Notch1 but Not Notch2 Is Essential for Generating Hematopoietic Stem Cells from Endothelial Cells (387 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Cardiology, Endocrinology, Pathology and Inflammation are his primary areas of study.
His work on Internal medicine is being expanded to include thematically relevant topics such as Diabetes mellitus.
His Cardiology research includes elements of Surgery and Diastole.
The concepts of his Endocrinology study are interwoven with issues in Receptor, Apolipoprotein E and Angiogenesis.
His Pathology research integrates issues from Neointimal hyperplasia and Neointima.
His work in Bone marrow tackles topics such as Progenitor cell which are related to areas like Endothelial stem cell and Immunology.
He most often published in these fields:
- Internal medicine (57.61%)
- Cardiology (31.42%)
- Endocrinology (25.06%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (57.61%)
- Cardiology (31.42%)
- Inflammation (9.85%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cardiology, Inflammation, Heart failure and In patient.
Masataka Sata interconnects Diabetes mellitus, Endocrinology and Type 2 diabetes in the investigation of issues within Internal medicine.
His Cardiology study deals with Clinical endpoint intersecting with Hazard ratio.
The Inflammation study combines topics in areas such as Adipose tissue, Receptor and Pathogenesis, Pathology.
The concepts of his Heart failure study are interwoven with issues in Randomized controlled trial and Stress Echocardiography.
As part of one scientific family, he deals mainly with the area of Endothelial dysfunction, narrowing it down to issues related to the Apolipoprotein E, and often Deficient mouse.
Between 2016 and 2021, his most popular works were:
- Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus (52 citations)
- A Deep Learning Approach for Assessment of Regional Wall Motion Abnormality From Echocardiographic Images (45 citations)
- Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD‐J (Flow‐Mediated Dilation Japan) Study A (36 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cardiology
The scientist’s investigation covers issues in Internal medicine, Cardiology, Inflammation, Endothelial dysfunction and Vasodilation.
The study incorporates disciplines such as Endocrinology, Type 2 diabetes and Type 2 Diabetes Mellitus in addition to Internal medicine.
His work on Canagliflozin as part of his general Endocrinology study is frequently connected to Nutrient, thereby bridging the divide between different branches of science.
His work is dedicated to discovering how Type 2 Diabetes Mellitus, Adipose tissue are connected with Adipokine, Pathogenesis, Pathology and Vasa vasorum and other disciplines.
His work on Ejection fraction and Heart failure as part of general Cardiology study is frequently linked to In patient, bridging the gap between disciplines.
His Inflammation research integrates issues from Apolipoprotein B, Receptor, Thermogenesis, Macrophage and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
